Compass Pathways Plc Overview
Valuation check: CMPS's P/E ratio is -2.46, below the Healthcare sector average of 25.9.
Get informed when a big investor buys or sells
+ Follow-2.46
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Compass Pathways Plc (CMPS) currently reports a P/E ratio of -2.46. That is below the Healthcare sector average of 25.9. Use the charts on this page to explore Compass Pathways Plc's P/E ratio history and peer comparisons.
Compass Pathways Plc's P/E ratio of -2.46 is lower than the Healthcare sector average of 25.9. That is roughly 109.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Compass Pathways Plc's market price to a fundamental measure such as earnings, sales, or book value. At -2.46, CMPS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -2.46, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for Compass Pathways Plc, and consider following CMPS for alerts when major investors trade the stock.
Compass Pathways Plc is classified in the Healthcare sector. On P/E ratio, it currently shows -2.46 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMPS with unrelated industries.
